Endotronix raised another $25 million to conduct late-stage trials of an implantable device to help doctors better monitor cardiac patients and detect problems before they lead to heart failure.
The Lisle-based company raised $45 million a year ago in preparation for trials in Europe. It’s one of a handful of medical-device startups in Chicago that received significant funding.
If all goes well, Endotronix hopes to have its device in market in Europe either late next year or 2021 and in the U.S. the following year.